USFDA completes inspection at Lupin’s Somerset manufacturing facility

16 Jan 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Somerset, New Jersey, U.S.A. manufacturing facility. USFDA inspected the said facility from January 2, 2023 to January 13, 2023. The inspection closed with issuance of a Form-483 with two observations. The company is addressing the observations comprehensively and will work with the USFDA to resolve these issues at the earliest. The company upholds quality and compliance with utmost importance and is committed to be compliant with CGMP standards across all its facilities.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×